4D Molecular Therapeutics Inc (FDMT)
Cost of Revenue
$53.36M
TTM · Period ending: · USD
FDMT Cost of Revenue
Latest reported$53.36Mperiod ending
Latest reported$53.36Mperiod ending
FDMT TTM Cost of Revenue ($18.36M → $53.36M)
TTM cost of revenue
High-resolution chart · PNG
FDMT cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 53,362,000 | |
| 99,224,000 | |
| 137,868,000 | |
| 137,672,000 | |
| 128,918,000 | |
| 112,827,000 | |
| 99,998,000 | |
| 124,242,000 | |
| 110,824,000 | |
| 102,548,000 | |
| 97,090,000 | |
| 92,562,000 | |
| 86,436,000 | |
| 83,274,000 | |
| 80,243,000 | |
| 76,271,000 | |
| 73,171,000 | |
| 67,972,000 | |
| 61,360,000 | |
| 56,437,000 | |
| 52,152,000 | |
| 52,649,000 | |
| 53,038,000 | |
| 52,792,000 | |
| 50,611,000 | |
| 43,383,500 | |
| 38,718,000 | |
| 31,436,000 | |
| 27,139,000 | |
| 22,750,500 | |
| 18,362,000 |